All tenders
75F40121F80450
FDA CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) RISK EVALUATION AND MITIGATION STRATEGY (REMS) PRESCRIBER EDUCATION INNOVATION DEVELOPMENT COR: SAM CARTER EMAIL: SAMUEL.CARTER@FDA.HHS.GOV 3-WAY COST - REQUIRES CO APPROVAL
Food and Drug Administration · United States
This tender closed on Wednesday, November 30, 2022. Browse open opportunities
Time Left to Bid
Closed
ClosedEducation & TrainingFederal
Basic information
- Reference number
- 75F40121F80450
- Issuing organization
- Food and Drug Administration · Find award history →
- Government level
- Federal
- Solicitation type
- Education & Training
- Title
- FDA CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) RISK EVALUATION AND MITIGATION STRATEGY (REMS) PRESCRIBER EDUCATION INNOVATION DEVELOPMENT COR: SAM CARTER EMAIL: SAMUEL.CARTER@FDA.HHS.GOV 3-WAY COST - REQUIRES CO APPROVAL
- Source
- USASpending (Federal)
- Source ID
- usa-75F40121F80450
Details
- Location
- United States
Description
FDA CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) RISK EVALUATION AND MITIGATION STRATEGY (REMS) PRESCRIBER EDUCATION INNOVATION DEVELOPMENT COR: SAM CARTER EMAIL: SAMUEL.CARTER@FDA.HHS.GOV 3-WAY COST - REQUIRES CO APPROVAL Awarded to: THE MITRE CORPORATION Agency: Department of Health and Human Services Sub-agency: Food and Drug Administration Award type: DELIVERY ORDER
Dates
- Publication
- 2021/09/29 12:00:00 AM UTC
- Closing date
- 2022/11/30 12:00:00 AM UTC
Estimated value
$1.0M USD
Classification
Normalized category
Education & Training